Progestin regulation of galanin and prolactin gene expression in oestrogen-induced pituitary tumours.
Galanin is a peptide widely distributed in the hypothalamic-pituitary axis. In the female rat pituitary, galanin is mainly present in lactotrophs, where it regulates their secretion and proliferation. Galanin expression is increased in oestrogen-induced prolactinomas, and it has been proposed that oestrogen effects on lactotroph function and proliferation could be mediated by galanin. Previous studies from our laboratory demonstrated that the synthetic progestin levonorgestrel antagonizes pituitary tumorigenesis of rats given oestrogen, reducing the number of proliferating cells and increasing cell death by nonapoptotic mechanism(s). To elucidate the role of galanin in levonorgestrel effects on the tumours, we examined galanin and prolactin mRNA and peptide expression in prolactinomas of rats receiving the progestin. Levonorgestrel reduced the pituitary weight and serum prolactin concentrations in oestrogen-treated rats. Galanin mRNA expression (determined by in situ hybridization), and the number of galanin expressing cells (determined by immunocytochemistry) were also reduced by the progestin in tumour-bearing rats. However, neither prolactin mRNA content, nor the number of prolactin-expressing cells, were modified by levonorgestrel treatment of oestrogen-receiving rats. The present study suggests that levonorgestrel controls pituitary growth by diminishing galanin expression. In contrast, changes in serum prolactin concentration seem to be more related to the reduction in tumour size, since the reduction in galanin expression was not large enough to regulate prolactin mRNA expression or the percentage of lactotrophs.
Piroli
G G
GG
Laboratorio de Bioquímica Neuroendócrina, Instituto de Biología y Medicina Experimental, UBA-CONICET, Buenos Aires, Argentina. pirolig@rockvax.rockefeller.edu
Cassataro
J
J
Pietranera
L
L
Grillo
C A
CA
Ferrini
M
M
Lux-Lantos
V
V
De Nicola
A F
AF
D000818:Animals; D002452:Cell Count; D004054:Diethylstilbestrol; D005260:Female; D019004:Galanin / Q000032:analysis / Q000235:genetics*; D015870:Gene Expression / Q000187:drug effects; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D016912:Levonorgestrel / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010052:Ovariectomy; D010902:Pituitary Gland / Q000473:pathology; D010911:Pituitary Neoplasms / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D045167:Progesterone Congeners / Q000494:pharmacology*; D011388:Prolactin / Q000032:analysis / Q000097:blood / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344
D045167:Progesterone Congeners; D012333:RNA, Messenger; D016912:Levonorgestrel; D004054:Diethylstilbestrol; D019004:Galanin; D011388:Prolactin